Customer Satisfaction Survey 2019: THE RESULTS
Dexter - New surgical robot that provides affordability without compromise
Elemental has signed a three-year exclusive UK distribution agreement with Distalmotion.
With Dexter, hospitals can reduce the costs of surgery by more than 90% compared to traditional robotic solutions.
The 'Dexter' robot brings a totally new dimension to the clinical efficacy of robotic surgery, allowing a surgeon to swap from robotic to laparoscopic surgery and back as required within the sterile field. 'Dexter' will be CE marked in mid-2019 giving Elemental Healthcare time to train a dedicated team in preparation for its launch.
Elemental has signed a three-year exclusive UK distribution agreement with Distalmotion, the manufacturer of Dexter.
Adam Power, Group Development Director of Surgical Innovations Group plc, commented:
"The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate. 'Dexter' offers a much broader range of surgical opportunities and employs a novel funding model. As a consequence, we expect 'Dexter' by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals."
Dr Matthias Reif, Head of Sales and Marketing of DistalMotion SA commented:
"Elemental Healthcare is a proven partner to commercialise innovative technology, and we are excited to partner as we believe this is the best route to commercialise 'Dexter'. The UK market is among the largest medical device markets in Europe, and a key region for Distalmotion to prove robotic surgery can be simplified and integrated into laparoscopic surgery."
Read more about Dexter, here.